Showing results (441-450 of 671) with videos related to

Sort By:
Pageof 68
Surgery|November 6, 2018
Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accidentSarah B Fisher, Gilbert J Cote, Jacquelin H Bui-Griffith, et al.
Journal of Cutaneous Pathology|January 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotinWoo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Cancer Research|December 17, 2005
High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptorNobukazu Fujimoto, Marie Wislez, Jie Zhang, et al.
Cell Reports|August 2, 2016
Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung TumorigenesisMahesh S Padanad, Georgia Konstantinidou, Niranjan Venkateswaran, et al.
Cancer Discovery|February 20, 2019
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung CancerTriparna Sen, B Leticia Rodriguez, Limo Chen, et al.
Ebiomedicine|March 26, 2019
Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lungSmruthy Sivakumar, F Anthony San Lucas, Yasminka A Jakubek, et al.
Oncogene|January 26, 2016
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell propertiesA N Paranjape, R Soundararajan, S J Werden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agentsMuling Mao, Feng Tian, John M Mariadason, et al.
Carcinogenesis|July 1, 2020
Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancerShanshan Deng, Marco Ramos-Castaneda, Walter V Velasco, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2015
Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium ExperienceLynette M Sholl, Dara L Aisner, Marileila Varella-Garcia, et al.
Pageof 68